India's Strides Pharma rises on quarterly profit surge, boosted by US sales

Strides Pharma Science

22/05/2025 09:56

** Shares of Strides Pharma Science SRID.NS rise 2.4% to 709 rupees

** Co's Q4 consolidated net profit jumps nearly five-fold Y/Y to 856.2 mln rupees ($10 mln), revenue rose ~14%

** SRID says it beat its forecast on all key metrics, including revenue, EBITDA

** Adds, growth led by US business growth, up 21.8% Y/Y and new launches

** Stock up ~5.5% YTD, eyes extending rally for a fourth session

($1 = 85.9340 Indian rupees)

 (Reporting by Yagnoseni Das in Bengaluru)

 ((Yagnoseni.Das@thomsonreuters.com;))